Table 1 Patient characteristics for 508 patients recruited to study between March 2008 and June 2013
From: The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection
Patients included in analysis (n = 425) | Patients excluded from analysis for incomplete data (n = 76) | Patients excluded from analysis for no definitive diagnosis (n = 7) | ||
|---|---|---|---|---|
Male:female | 283:142 (67:33%) | 51:25 (67:33%) | 7:0 (100:0%) | |
Median age (IQR) | 72 (63–80) | 75 (69–78) | 81 (55.5–88.5) | |
Inpatient:outpatient | 179:246 (42:58%) | 36:39 (1 data not available) (47:51%) | 5:2 (71:29%) | |
Diagnosis | Metastatic malignancy | 169 (39.8%) | 32 (42.1%) | – |
Pleural infection | 80 (18.8%) | 11 (14.5%) | – | |
Malignant mesothelioma | 70 (16.5%) | 4 (5.3%) | – | |
Congestive cardiac failure | 41 (9.6%) | 7 (9.2%) | – | |
BAPE | 17 (4.0%) | 6 (7.9%) | – | |
Inflammatory pleuritis | 13 (3.1%) | 7 (9.2%) | – | |
Pleural TB | 10 (2.4%) | 0 | – | |
Other | 25 (5.9%) | 9 (11.8%) | – | |